Kala Pharmaceuticals: Funding, Investors & Team (Oct 2026)
Kala Pharmaceuticals is developing novel treatments for diseases that affect mucosal tissues. The company's proprietary mucus penetrating particle technology dramatically improves drug distribution and pharmacokinetics by uniformly coating the mucosal surface with biocompatible, drug-loaded particles. Kala's formulations achieve high, sustained local drug concentrations with reduced systemic exposure and are delivered in a patient friendly format. The company's research efforts have demonstrated successful in vivo proof-of-concept in mucosal organs such as the respiratory tract, eye, and cervicovaginal tract, enabling diverse product opportunities that target significant clinical unmet need. Kala is focused on advancing an internal pipeline of products through human proof-of-concept, while establishing R&D collaborations with select partners to improve products in their pipelines.
Kala Pharmaceuticals has raised $125M across 1 funding round on record, the most recent an undisclosed round of $125M announced in May 2021.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Kala Pharmaceuticals Company Profile and Key Stats
Latest funding round on record: May 2021.
Kala Pharmaceuticals Funding Rounds
Kala Pharmaceuticals Founders and Leadership Team
Contact details for the Kala Pharmaceuticals team: 1 of 1 has an email address on file.
Start 14-day free trial →Kala Pharmaceuticals Funding Compared to Other Biotechnology Startups
Kala Pharmaceuticals' latest round of $125M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Kala Pharmaceuticals in Biotechnology and Waltham
Companies Similar to Kala Pharmaceuticals
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Kala Pharmaceuticals Funding FAQs
What does Kala Pharmaceuticals do?
Kala Pharmaceuticals is developing novel treatments for diseases that affect mucosal tissues. The company's proprietary mucus penetrating particle technology dramatically improves drug distribution and pharmacokinetics by uniformly coating the mucosal surface with biocompatible, drug-loaded particles. Kala's formulations achieve high, sustained local drug concentrations with reduced systemic exposure and are delivered in a patient friendly format. The company's research efforts have demonstrated successful in vivo proof-of-concept in mucosal organs such as the respiratory tract, eye, and cervicovaginal tract, enabling diverse product opportunities that target significant clinical unmet need. Kala is focused on advancing an internal pipeline of products through human proof-of-concept, while establishing R&D collaborations with select partners to improve products in their pipelines.
How much funding has Kala Pharmaceuticals raised?
Kala Pharmaceuticals has raised $125M across 1 round on record. The most recent is an undisclosed round of $125M announced in May 2021.
When did Kala Pharmaceuticals last raise funding?
Kala Pharmaceuticals' most recent funding round on record is an undisclosed round of $125M, announced in May 2021.
Who is the CEO of Kala Pharmaceuticals?
Mark Iwicki is listed as CEO at Kala Pharmaceuticals.
Where is Kala Pharmaceuticals headquartered?
Kala Pharmaceuticals is based in Waltham, Massachusetts, United States.
How many employees does Kala Pharmaceuticals have?
Kala Pharmaceuticals is in the 101-250 employee band.
How does Kala Pharmaceuticals' funding compare to other Biotechnology startups?
Kala Pharmaceuticals' latest round of $125M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Kala Pharmaceuticals Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Kala Pharmaceuticals is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.